Researchers identify novel target that could improve the safety of CAR T cell therapy for pancreatic cancer
Human pancreatic cancer model offers new opportunities for testing drugs
22 January 2021South African scientists who discovered new COVID-19 variant share what they know
22 January 2021Researchers identify novel target that could improve the safety of CAR T cell therapy for pancreatic cancer
Researchers from Queen Mary University of London, have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer. Using this protein as a target, the team successfully created a CAR T cell therapy—a type of immunotherapy—that killed pancreatic cancer cells in a pre-clinical model.
